Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research

    Sep 24, 2024, 09:08 AM by
    Full story
  • A Pill That Triggers a Desire to Exercise? Maybe... For Now, Just Go to the Gym

    Sep 24, 2024, 01:00 AM by User Not Found
    Bio-IT World | What Wegovy has done for people who want to lose weight but dislike the work involved might one day find its match with a pill that pumps up a person’s desire to exercise—all by adjusting their level of interleukin 15 (IL-15), a cytokine that in the brain stimulates locomotor activity. At least that’s one of the promising possibilities dredged up by a study in mice finding a muscle-brain pathway controlling “eagerness to train more when we exercise."
    Full story
  • The Rise and Importance of Population-Scale Genome Programs

    Sep 20, 2024, 01:00 AM by User Not Found
    Bio-IT World | With the wealth of population-scale projects going on, we have entered a golden age of genomics. Based on efforts such as the All of Us program in the U.S. and the UK Biobank, among many others, we are poised to discover more than we ever knew about natural genetic diversity, what’s considered “normal” human biology, and the continuum of health and disease.
    Full story
  • Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit

    Sep 19, 2024, 10:07 AM by
    Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents a significant advancement in nucleic acid purification.
    Full story
  • MATTER Selected to Lead the Digital Health Hub in the Next Generation of the BARDA Accelerator Network

    Sep 19, 2024, 10:07 AM by
    The Biomedical Advanced Research and Development Authority (BARDA) has selected MATTER to lead the new Digital Health Hub as part of the BARDA Accelerator Network. The hub, called Paratus, will support the development of next-gen digital health technologies to address health security threats.
    Full story
  • Watson-Marlow Fluid Technology Solutions showcases recently launched WMArchitect™ single-use solutions along with a range of pumps and hoses at CPHI Milan 2024

    Sep 19, 2024, 10:07 AM by
    Watson-Marlow Fluid Technology Solutions (WMFTS) will display a range of peristaltic pumps and associated fluid path technologies for the life sciences industry during CPHI Milan 2024 at Fiera Milano on 8th – 10th October.
    Full story
  • CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence

    Sep 19, 2024, 10:07 AM by
    Phreesia, the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina Escobar, MD, at New York University, are proud to announce that the U.S. Centers for Disease Control and Prevention (CDC) has awarded a grant for a joint project focused on combating the public health challenge of urinary incontinence in women.
    Full story
  • Sapio Sciences Partner Program Welcomes Astrix

    Sep 19, 2024, 10:07 AM by
    Sapio Sciences, the science-aware™ lab informatics platform, today announced that Astrix, the market leader in creating and delivering innovative strategies, solutions, and people to the life science community, has joined the Sapio Sciences Partner Program, providing consulting and implementation services to life science and biotech customers.
    Full story
  • 2025 Bio-IT World Innovative Practices Awards Call for Entries

    Sep 18, 2024, 01:00 AM by User Not Found
    Bio-IT World | Bio-IT World is accepting entries for the 2025 Innovative Practices Awards, a competition designed to recognize the most exciting partnerships and projects pushing the life sciences industry forward.
    Full story
  • NVIDIA Bundles NIMs for GenAI Drug Target Screening

    Sep 17, 2024, 01:00 AM by User Not Found
    Bio-IT World | Last June, NVIDIA launched NIM—NVIDIA Inference Microservices—a simple, standardized way to add generative AI to applications. Now the company has released the NIM Agent Blueprint for generative AI-based virtual screening. In a blog post announcing the news, NVIDIA describes a NIM Agent Blueprint as integrated NIMs that build a workflow.
    Full story
  • Global Cyber Security Expert, NCC Group Expands Digital Identity Services Amidst Growing Customer Demand

    Sep 16, 2024, 06:40 AM by
    NCC Group has launched a new suite of digital identity services to help organizations manage and safeguard access to their digital assets, while optimizing operations and enhancing security.
    Full story
  • eClinical Solutions Announces Growth Investment by GI Partners to Further Its Mission of Helping Bring Treatments to Patients Faster

    Sep 16, 2024, 06:40 AM by
    eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that GI Partners, a private investment firm, has made a majority investment in the company to advance the future of digital trials via continued enhancements to its leading AI-powered data products and biometrics services.
    Full story
  • Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler

    Sep 13, 2024, 08:44 AM by
    Opentrons introduces Flex Prep, a no-code robot combining the simplicity of a pipette with the versatility of a liquid handler. Its intuitive touchscreen allows scientists to program pipetting tasks in under a minute. Flex Prep enhances lab automation, offering affordable and versatile capabilities for both basic and complex protocols, empowering researchers to automate tasks without prior robotics experience.
    Full story
  • Sunrise Labs, Inc. Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network

    Sep 13, 2024, 08:44 AM by
    Full story
  • Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform

    Sep 13, 2024, 08:44 AM by
    Cellares and Sony have announced a collaboration to integrate Sony’s flow cytometry-based sorting technology into Cellares' automated Cell Shuttle platform for cell therapy manufacturing. This integration will enhance automation, scalability, and real-time monitoring, improving the efficiency of sorting-dependent therapies like Treg and HSC. It aims to streamline the manufacturing process and reduce costs.
    Full story
  • Cleveland Diagnostics’ Prostate Cancer Awareness Campaign ‘A PSA on PSA’ Returns This September

    Sep 12, 2024, 07:12 AM by
    National Initiative to Increase Education & Awareness; Raise Funds for ZERO Prostate Cancer with Donation Made for Every Patient Discussion Guide Downloaded at PSAonPSA.com
    Full story
  • GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research

    Sep 12, 2024, 07:12 AM by
    GenNext Technologies has announced a pioneering collaboration with Agilent, that promises to transform structural biology research for biopharmaceutical companies.
    Full story
  • Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development

    Sep 12, 2024, 07:12 AM by
    In a research collaboration with Oxford Nanopore Technologies, scientists from the University of Washington have unveiled a groundbreaking ‘proof-of-concept’ method for reading single protein molecules
    Full story
  • ‘Dancing Molecules’ Could Be the Key to Cartilage Regeneration

    Sep 12, 2024, 01:00 AM by User Not Found
    Bio-IT World | Osteoarthritis affects more than 528 million people around the world. Cartilage in joints wears down, and bones rub against each other, causing pain, stiffness, and mobility issues. Current treatments slow down cartilage degeneration, though patients inevitably need expensive joint replacement surgery. However, researchers at Northwestern University discovered “dancing molecules” that might be the key to the first cartilage regenerative therapy.
    Full story
  • PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

    Sep 11, 2024, 09:32 AM by
    PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.
    Full story
  • «
  • 21 (current)
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy